메뉴 건너뛰기




Volumn 125, Issue SUPPL. 1, 2010, Pages 83-94

Costs of HIV prevention among out-of-treatment drug-using women: Results of a randomized controlled trial

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG USE; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH HAZARD; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; ADDICTION; CONDOM; COST; ECONOMICS; PATIENT EDUCATION; VAGINA SMEAR;

EID: 77952522088     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/00333549101250s111     Document Type: Article
Times cited : (17)

References (26)
  • 1
    • 33645812933 scopus 로고    scopus 로고
    • What works, and what remains to be done, in HIV prevention in the United States
    • Holtgrave DR, Curran JW. What works, and what remains to be done, in HIV prevention in the United States. Annu Rev Public Health 2006;27:261-75.
    • (2006) Annu Rev Public Health , vol.27 , pp. 261-275
    • Holtgrave, D.R.1    Curran, J.W.2
  • 3
    • 0033933945 scopus 로고    scopus 로고
    • Costeffectiveness of an HIV risk reduction intervention for adults with severe mental illness
    • Johnson-Masotti AP, Pinkerton SD, Kelly JA, Stevenson LY. Costeffectiveness of an HIV risk reduction intervention for adults with severe mental illness. AIDS Care 2000;12:321-32.
    • (2000) AIDS Care , vol.12 , pp. 321-332
    • Johnson-Masotti, A.P.1    Pinkerton, S.D.2    Kelly, J.A.3    Stevenson, L.Y.4
  • 5
    • 0034298216 scopus 로고    scopus 로고
    • Economic evaluation of HIV risk reduction intervention in African-American male adolescents
    • Pinkerton SD, Holtgrave DR, Jemmott JD 3rd. Economic evaluation of HIV risk reduction intervention in African-American male adolescents. J Acquir Immune Defic Syndr 2000;25:164-72.
    • (2000) J Acquir Immune Defic Syndr , vol.25 , pp. 164-172
    • Pinkerton, S.D.1    Holtgrave, D.R.2    Jemmott III, J.D.3
  • 6
    • 1642586910 scopus 로고    scopus 로고
    • Disseminating effective behavioral interventions for HIV prevention: A cost analysis of a risk-reduction intervention for drug users
    • Trentacoste ND, Holtgrave DR, Collins C, Abdul-Quader A. Disseminating effective behavioral interventions for HIV prevention: a cost analysis of a risk-reduction intervention for drug users. J Public Health Manag Pract 2004;10:130-9.
    • (2004) J Public Health Manag Pract , vol.10 , pp. 130-139
    • Trentacoste, N.D.1    Holtgrave, D.R.2    Collins, C.3    Abdul-Quader, A.4
  • 7
    • 0035006020 scopus 로고    scopus 로고
    • The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV
    • Zarkin GA, Lindrooth RC, Demiralp B, Wechsberg W. The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV. Health Serv Res 2001;36:335-55.
    • (2001) Health Serv Res , vol.36 , pp. 335-355
    • Zarkin, G.A.1    Lindrooth, R.C.2    Demiralp, B.3    Wechsberg, W.4
  • 9
    • 0029818727 scopus 로고    scopus 로고
    • Are we reaching and enrolling at-risk drug users for prevention studies?
    • Cunningham RM, Cottler LB, Compton WM. Are we reaching and enrolling at-risk drug users for prevention studies? J Drug Issues 1996;26:541-60.
    • (1996) J Drug Issues , vol.26 , pp. 541-560
    • Cunningham, R.M.1    Cottler, L.B.2    Compton, W.M.3
  • 12
    • 0029764812 scopus 로고    scopus 로고
    • A method to measure the costs of counseling for HIV prevention
    • Gorsky RD. A method to measure the costs of counseling for HIV prevention. Public Health Rep 1996;111(Suppl 1):115-22.
    • (1996) Public Health Rep , vol.111 , Issue.SUPPL. 1 , pp. 115-122
    • Gorsky, R.D.1
  • 15
    • 0030919507 scopus 로고    scopus 로고
    • Economic foundations of cost-effectiveness analysis
    • Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ 1997;16:1-31.
    • (1997) J Health Econ , vol.16 , pp. 1-31
    • Garber, A.M.1    Phelps, C.E.2
  • 16
    • 0025182087 scopus 로고
    • Estimating costs in the economic evaluation of medical technologies
    • Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 1990; 6:57-75.
    • (1990) Int J Technol Assess Health Care , vol.6 , pp. 57-75
    • Luce, B.R.1    Elixhauser, A.2
  • 17
    • 0030783238 scopus 로고    scopus 로고
    • Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs
    • Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:54-62.
    • (1997) J Acquir Immune Defic Syndr Hum Retrovirol , vol.16 , pp. 54-62
    • Holtgrave, D.R.1    Pinkerton, S.D.2
  • 19
    • 27944432137 scopus 로고    scopus 로고
    • Using economic threshold analysis to determine the intensity of HIV prevention services for HIV-seropositive persons
    • Holtgrave DR. Using economic threshold analysis to determine the intensity of HIV prevention services for HIV-seropositive persons. AIDS 2005;19:2025-9.
    • (2005) AIDS , vol.19 , pp. 2025-2029
    • Holtgrave, D.R.1
  • 20
    • 33750562166 scopus 로고    scopus 로고
    • The lifetime cost of current human immunodeficiency virus care in the United States
    • Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006;44:990-7.
    • (2006) Med Care , vol.44 , pp. 990-997
    • Schackman, B.R.1    Gebo, K.A.2    Walensky, R.P.3    Losina, E.4    Muccio, T.5    Sax, P.E.6
  • 22
    • 0032538250 scopus 로고    scopus 로고
    • The importance of simple/rapid assays in HIV testing
    • Also available from: URL: [cited 2005 Nov 31]
    • World Health Organization. The importance of simple/rapid assays in HIV testing. Wkly Epidemiol Rec 1998;73:321-8. Also available from: URL: http://www.who.int/wer/pdf/1998/wer7342.pdf [cited 2005 Nov 31].
    • (1998) Wkly Epidemiol Rec , vol.73 , pp. 321-328
  • 23
    • 0036298731 scopus 로고    scopus 로고
    • Estimating the cost of unmet HIV-prevention needs in the United States
    • Holtgrave DR, Pinkerton SD, Merson M. Estimating the cost of unmet HIV-prevention needs in the United States. Am J Prev Med 2002;23:7-12.
    • (2002) Am J Prev Med , vol.23 , pp. 7-12
    • Holtgrave, D.R.1    Pinkerton, S.D.2    Merson, M.3
  • 24
    • 0035805250 scopus 로고    scopus 로고
    • Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV
    • Pinkerton SD, Johnson-Masotti AP, Holtgrave DR, Farnham PG. Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV. AIDS 2001;15:917-28.
    • (2001) AIDS , vol.15 , pp. 917-928
    • Pinkerton, S.D.1    Johnson-Masotti, A.P.2    Holtgrave, D.R.3    Farnham, P.G.4
  • 25
    • 0345130068 scopus 로고    scopus 로고
    • Panel on cost-effectiveness in health and medicine recommendations: Identifying costs
    • Manning WG Jr. Panel on cost-effectiveness in health and medicine recommendations: identifying costs. J Clin Psychiatry 1999;60(Suppl 3):54-6.
    • (1999) J Clin Psychiatry , vol.60 , Issue.SUPPL. 3 , pp. 54-56
    • Manning Jr., W.G.1
  • 26
    • 3242702953 scopus 로고    scopus 로고
    • Combating HIV/AIDS in developing countries
    • Ruger JP. Combating HIV/AIDS in developing countries. BMJ 2004; 329:121-2.
    • (2004) BMJ , vol.329 , pp. 121-122
    • Ruger, J.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.